Up-frameshift protein 1 (UPF1): Multitalented entertainer in RNA decay.

Imamachi N, Tani H, Akimitsu N

Drug Discov Ther. 2012; 6(2):55-61.

DOI: 10.5582/ddt.2012.v6.2.55

Summary Full Text (PDF)

A facile method for the synthesis of N-(α-aminoacyl) sulfonamides.

Wu SL, Chen ML, Wang YT, Hou XB, Yang XY, Su L, Fang H

Drug Discov Ther. 2012; 6(2):62-68.

DOI: 10.5582/ddt.2012.v6.2.62

Summary Full Text (PDF)

In silico ligand based design of indolylpiperidinyl derivatives as novel histamine H₁ receptor antagonists.

Paliwal S, Singh S, Pal M

Drug Discov Ther. 2012; 6(2):69-77.

DOI: 10.5582/ddt.2012.v6.2.69

Summary Full Text (PDF)

Synthesis, analgesic, anti-inflammatory and ulcerogenic properties of some novel N'-((1-(substituted amino)methyl)-2-oxoindolin-3-ylidene)-4-(2-(methyl/phenyl)-4-oxoquinazolin-3(4H)-yl)benzohydrazide derivatives.

Saravanan G, Alagarsamy V, Prakash CR

Drug Discov Ther. 2012; 6(2):78-87.

DOI: 10.5582/ddt.2012.v6.2.78

Summary Full Text (PDF)

Evaluation of innate immune stimulating activity of polysaccharides using a silkworm (Bombyx mori) muscle contraction assay.

Fujiyuki T, Hamamoto H, Ishii K, Urai M, Kataoka K, Takeda T, Shibata S, Sekimizu K

Drug Discov Ther. 2012; 6(2):88-93.

DOI: 10.5582/ddt.2012.v6.2.88

Summary Full Text (PDF)

Regulation of Janus-activated kinase-2 (JAK2) by diindolylmethane in ovarian cancer in vitro and in vivo.

Kandala PK, Srivastava SK

Drug Discov Ther. 2012; 6(2):94-101.

DOI: 10.5582/ddt.2012.v6.2.94

Summary Full Text (PDF)

Analyzing global trends of biomarker use in drug interventional clinical studies.

Hayashi K, Masuda S, Kimura H

Drug Discov Ther. 2012; 6(2):102-107.

DOI: 10.5582/ddt.2012.v6.2.102

Summary Full Text (PDF)

Standardization of perioperative management on hepato-biliary-pancreatic surgery.

Gao JJ, Song PP, Tamura S, Hasegawa K, Sugawara Y, Kokudo N, Uchida K, Orii R, Qi FH, Dong JH, Tang W

Drug Discov Ther. 2012; 6(2):108-111.

DOI: 10.5582/ddt.2012.v6.2.108

Summary Full Text (PDF)